Dr. Lemmon will step into his role July 1, according to a Nov. 22 news release from the university. He succeeds Joseph Schlessinger, PhD, who led the department for more than two decades.
Currently, Dr. Lemmon is deputy director of the Yale Cancer Center and co-director of the Yale Cancer Biology Institute.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
